- News Home
12 December 2013 1:00 pm ,
Vol. 342 ,
Stefan Behnisch has won awards for designing science labs and other buildings that are smart, sustainable, and...
The iconic 125-year-old Lick Observatory on Mount Hamilton near San Jose, California, is facing the threat of closure...
Recent results from the Curiosity Mars rover have helped scientists formulate a plan for the next phase of its mission...
A new, remarkably powerful drug that cripples the hepatitis C virus (HCV) came to market last week, but it sells for $...
In pretoothbrush populations, gumlines would often be marred by a thick, visible crust of calcium phosphate, food...
Evolutionary biologists have long studied how the Mexican tetra, a drab fish that lives in rivers and creeks but has...
Victorian astronomers spent countless hours laboriously charting the positions of stars in the sky. Such sky mapping,...
In an ambitious project to study 1000 years of sickness and health, researchers are excavating the graveyard of the now...
- 12 December 2013 1:00 pm , Vol. 342 , #6164
- About Us
European Agency's Final Verdict on Controversial GM Study: Not Scientifically Sound
28 November 2012 6:05 pm
The European Food Safety Authority (EFSA) today delivered its final verdict on a controversial study that examined the toxicity of genetically modified (GM) maize. The study "does not meet acceptable scientific standards" and there is therefore no need to reevaluate the safety of GM maize, the group concluded.
The study in question was published on 19 September in Food and Chemical Toxicology by molecular biologist Gilles-Eric Séralini and colleagues. It claimed to find a link between GM maize NK603 and tumors and death in rats. Although the study was panned by scientists, it received an enormous amount of attention from both the French public and press.
At the request of the European Commission, EFSA set up a task force to look into the study; an initial review on 4 October deemed the research "inconclusive." Two French regulatory bodies also came to a similar conclusion in October.
Now, after completing its own assessment as well as taking into account independent assessments from Belgium, Denmark, France, Germany, Italy, and the Netherlands, EFSA has found the Seralini study wanting. The study is "of insufficient scientific quality for risk assessment" due to "inadequacies in the design, reporting and analysis of the study," the agency says.